StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)
StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the stock. Several other analysts have also issued reports on the stock. Maxim Group lowered shares of Moleculin Biotech from a “buy” rating to a “hold” rating […]
StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the stock. Several other analysts have also issued reports on the stock. Maxim Group lowered shares of Moleculin Biotech from a “buy” rating to a “hold” rating […]
